Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Moodys
Fuji
Argus Health
US Department of Justice
Fish and Richardson
Harvard Business School
McKinsey
Cipla
Johnson and Johnson

Generated: February 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 205650

« Back to Dashboard

NDA 205650 describes PYRIDOSTIGMINE BROMIDE, which is a drug marketed by Alvogen Malta, Impax Labs Inc, Kinedexe Uk, Ani Pharms Inc, Impax Labs, Solvay, Us Army, and Zydus Pharms Usa Inc, and is included in nine NDAs. It is available from seven suppliers. Additional details are available on the PYRIDOSTIGMINE BROMIDE profile page.

The generic ingredient in PYRIDOSTIGMINE BROMIDE is pyridostigmine bromide. There are eleven drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the pyridostigmine bromide profile page.
Summary for 205650
Tradename:PYRIDOSTIGMINE BROMIDE
Applicant:Zydus Pharms Usa Inc
Ingredient:pyridostigmine bromide
Patents:0
Therapeutic Class:Antimyasthenic Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 205650
Mechanism of ActionCholinesterase Inhibitors
Medical Subject Heading (MeSH) Categories for 205650
Suppliers and Packaging for NDA: 205650
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PYRIDOSTIGMINE BROMIDE pyridostigmine bromide TABLET;ORAL 205650 ANDA Major Pharmaceuticals 0904-6622 N 0904-6622-61
PYRIDOSTIGMINE BROMIDE pyridostigmine bromide TABLET;ORAL 205650 ANDA Bryant Ranch Prepack 63629-5699 N 63629-5699-1

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength60MG
Approval Date:Jun 22, 2015TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Federal Trade Commission
Queensland Health
Deloitte
Chubb
UBS
Moodys
Cantor Fitzgerald
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot